← FDA Drug Approvals (Drugs@FDA)

CLOBETASOL PROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2017-04-28

Drug application

FDA Application #

ANDA207218

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOBETASOL PROPIONATE

Generic name

Clobetasol Propionate

Active ingredients

CLOBETASOL PROPIONATE

Dosage form

SPRAY

Route

TOPICAL

Marketing status

Discontinued

Sponsor

SCIEGEN PHARMS

First approval

2017-04-28

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown